BeOne Medicines AG (BEIGF)
OTCMKTS
· Delayed Price · Currency is USD
24.92
0.00 (0.00%)
At close: Nov 10, 2025
BeOne Medicines AG Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 68.55 | -644.79 | -881.71 | -2,004 | -1,458 | -1,625 | Upgrade
|
| Depreciation & Amortization | 146.31 | 167.03 | 83.94 | 63.05 | 45.49 | 31.79 | Upgrade
|
| Other Amortization | 9.64 | 4.73 | 3.74 | 3.23 | 0.97 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | -35.77 | -13.23 | -8.49 | -27.74 | -28.99 | -4.49 | Upgrade
|
| Loss (Gain) From Sale of Investments | 58.24 | 24.02 | 16.22 | 22 | -7.63 | -11.83 | Upgrade
|
| Stock-Based Compensation | 494.71 | 441.62 | 367.62 | 303.16 | 240.71 | 183.48 | Upgrade
|
| Other Operating Activities | 35.23 | 37.15 | -368.23 | 11.11 | 26.89 | -8.03 | Upgrade
|
| Change in Accounts Receivable | -292.99 | -329.44 | -188.31 | 304.11 | -423.02 | 10.36 | Upgrade
|
| Change in Inventory | -102.05 | -91.5 | -140.95 | -56.69 | -153.33 | -58.91 | Upgrade
|
| Change in Accounts Payable | 100.58 | 121.5 | 21.48 | -4.35 | 20.01 | 95.84 | Upgrade
|
| Change in Unearned Revenue | 0.63 | 0.63 | -255.59 | -151.82 | 407.7 | - | Upgrade
|
| Change in Other Net Operating Assets | 302.31 | 141.64 | 192.82 | 41.14 | 30.3 | 103.29 | Upgrade
|
| Operating Cash Flow | 785.39 | -140.63 | -1,157 | -1,497 | -1,299 | -1,283 | Upgrade
|
| Capital Expenditures | -240.8 | -492.66 | -561.9 | -325.43 | -262.94 | -117.51 | Upgrade
|
| Sale (Purchase) of Intangibles | -80.69 | -36.47 | -34.37 | -143.67 | -51.91 | -109.5 | Upgrade
|
| Investment in Securities | -17.21 | -16.35 | 658.34 | 1,548 | 955.51 | -2,939 | Upgrade
|
| Other Investing Activities | 7.27 | -2.86 | -2.08 | -1.49 | - | -2.03 | Upgrade
|
| Investing Cash Flow | -331.43 | -548.35 | 60 | 1,077 | 640.66 | -3,168 | Upgrade
|
| Short-Term Debt Issued | - | 868.27 | 661.53 | 313.77 | 406.45 | 323.7 | Upgrade
|
| Long-Term Debt Issued | - | 9.05 | 22.5 | 37.37 | 16.84 | 110.21 | Upgrade
|
| Total Debt Issued | 765.38 | 877.32 | 684.03 | 351.15 | 423.29 | 433.91 | Upgrade
|
| Short-Term Debt Repaid | - | -704.22 | -309.58 | -417.08 | -321.75 | -12.25 | Upgrade
|
| Long-Term Debt Repaid | - | -28.03 | -13.69 | - | - | -132.06 | Upgrade
|
| Total Debt Repaid | -854.02 | -732.25 | -323.27 | -417.08 | -321.75 | -144.31 | Upgrade
|
| Net Debt Issued (Repaid) | -88.64 | 145.08 | 360.77 | -65.94 | 101.53 | 289.6 | Upgrade
|
| Issuance of Common Stock | 185.83 | 45.37 | 55.71 | 46.96 | 3,535 | 4,325 | Upgrade
|
| Other Financing Activities | 885 | 3 | - | - | - | 588.11 | Upgrade
|
| Financing Cash Flow | 958 | 193.45 | 416.48 | -18.97 | 3,637 | 5,203 | Upgrade
|
| Foreign Exchange Rate Adjustments | -14.85 | -51.71 | -8.08 | -69.38 | 14.04 | 18.23 | Upgrade
|
| Net Cash Flow | 1,397 | -547.24 | -689.05 | -507.85 | 2,993 | 769.23 | Upgrade
|
| Free Cash Flow | 544.6 | -633.29 | -1,719 | -1,822 | -1,562 | -1,401 | Upgrade
|
| Free Cash Flow Margin | 10.95% | -16.62% | -69.93% | -128.68% | -132.76% | -453.57% | Upgrade
|
| Free Cash Flow Per Share | 4.89 | -6.01 | -16.47 | -17.67 | -16.83 | -16.78 | Upgrade
|
| Cash Interest Paid | 49.16 | 51.18 | 19.75 | 25.17 | 29.97 | 44.13 | Upgrade
|
| Cash Income Tax Paid | 94.61 | 69.43 | 56 | 29.5 | 15.7 | 10.6 | Upgrade
|
| Levered Free Cash Flow | 349.76 | -367 | -1,274 | -943.69 | -1,204 | -752.29 | Upgrade
|
| Unlevered Free Cash Flow | 366.16 | -357.79 | -1,271 | -931.75 | -1,186 | -741.06 | Upgrade
|
| Change in Working Capital | 8.48 | -157.17 | -370.54 | 132.39 | -118.35 | 150.58 | Upgrade
|
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.